Upstream Bio (UPB) Receivables - Other (2023 - 2025)

Upstream Bio (UPB) has 3 years of Receivables - Other data on record, last reported at $1.6 million in Q3 2025.

  • For Q3 2025, Receivables - Other rose 234.85% year-over-year to $1.6 million; the TTM value through Sep 2025 reached $1.6 million, up 234.85%, while the annual FY2024 figure was $567000.0, 310.87% up from the prior year.
  • Receivables - Other reached $1.6 million in Q3 2025 per UPB's latest filing, down from $1.7 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $1.7 million in Q2 2025 and bottomed at $138000.0 in Q4 2023.
  • Average Receivables - Other over 3 years is $948833.3, with a median of $869500.0 recorded in 2024.
  • Peak YoY movement for Receivables - Other: skyrocketed 310.87% in 2024, then soared 234.85% in 2025.
  • A 3-year view of Receivables - Other shows it stood at $138000.0 in 2023, then surged by 310.87% to $567000.0 in 2024, then surged by 186.42% to $1.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables - Other were $1.6 million in Q3 2025, $1.7 million in Q2 2025, and $1.2 million in Q1 2025.